PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.78
Bid: 42.66
Ask: 42.76
Change: -0.38 (-0.88%)
Spread: 0.10 (0.234%)
Open: 42.16
High: 43.04
Low: 42.16
Prev. Close: 43.16
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital Markets Event

8 Feb 2024 14:00

RNS Number : 4858C
Assura PLC
08 February 2024

8 February 2024

Assura plc

Capital markets event

Assura plc ("Assura"), the leading primary care property investor and developer, is today hosting a capital markets presentation and site tour for analysts and institutional investors.

Assura has identified several areas of emerging opportunities (NHS Trusts, private providers, mental health and Ireland) that are now becoming meaningful contributors to our portfolio, rental income and cash flow.

Members of the senior management team will present an update on our strategic approach to these emerging opportunities, outlining why we are targeting these areas alongside our existing GP medical centres and how our skills and capabilities mean we are well placed to become a market leader.

Specifically focused on the private market, the presentation will detail:

· The state of the UK healthcare market and resultant increasing demand for high-quality, sustainable healthcare buildings in a community setting

· Overview of trends and market opportunity in the private market segment

· Assura's capabilities in capturing this opportunity; to complement its existing GP centre portfolio

· An overview of recent private market development completions

· Recent investments and asset enhancements within the mental health segment will also be highlighted

There will be a subsequent site tour to showcase Assura's recently completed, state-of-the-art cancer care facility in Guildford.

Jonathan Murphy, CEO of Assura, said: "There is significant demand for high-quality, sustainable healthcare buildings in a community setting to alleviate the considerable and growing pressures facing the NHS whilst improving the significantly underinvested existing estate. Each of these emerging areas is closely aligned with Assura's existing portfolio to relieve pressure on the health system; has attractive investment characteristics with a strong underlying tenant covenant and offers opportunities for future growth, which Assura is well placed to capture."

No new material trading information will be disclosed. A copy of the presentation is available on the Assura plc website at: https://www.assuraplc.com/investor-relations/reports-and-presentations

- ENDS -

Assura plc David Purcell, Investor Relations Director

Tel: 0161 515 2043 Email: Investor@assura.co.uk

FGS Global

Gordon SimpsonGrace Whelan

Tel: 0207 251 3801 Email: Assura@fgsglobal.com

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.

A constituent of the FTSE 250 and the EPRA* indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026.

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
UPDUWAWRSBUURRR
Date   Source Headline
1st Feb 20167:00 amRNSTotal Voting Rights
29th Jan 20162:00 pmRNSNotification of Vesting of Share Award to PDMR
22nd Jan 20167:00 amRNSAcquisition and Issue of Consideration Shares
19th Jan 20162:12 pmRNSScrip Dividend Declaration
6th Jan 20167:00 amRNSDirector/PDMR Shareholding
24th Dec 20157:00 amRNSScrip Calculation Price
22nd Dec 20155:06 pmRNSDirector/PDMR Shareholding
9th Dec 20157:00 amRNSNotice of Dividend & Introduction of Scrip Scheme
19th Nov 20157:00 amRNSInterim Results 2015
12th Nov 20157:00 amRNSDebt Redemption
2nd Nov 201512:14 pmRNSAcquisition and Issue of Consideration Shares
15th Oct 20151:53 pmRNSNotification of Major Interest in Shares
14th Oct 20155:10 pmRNSDirector/PDMR Shareholdings
13th Oct 201511:58 amRNSConfirmation of Quarterly Interim Dividend
12th Oct 20152:27 pmRNSResult of General Meeting
12th Oct 20157:00 amRNSResult of Proposed Share Issue
1st Oct 20159:59 amRNSTotal Voting Rights
28th Sep 20155:49 pmRNSPDMR Sale of Shares under VCP
25th Sep 20155:50 pmRNSAward and Exercise of Nil Cost Options under VCP
24th Sep 20154:53 pmRNSPublication of Prospectus
24th Sep 20157:00 amRNSProposed Share Issue and Notice of GM
8th Sep 20155:41 pmRNSTR1 Notification of Major Interest in Shares
13th Aug 201511:02 amRNSAnnual Information Update
21st Jul 20155:44 pmRNSResult of AGM
21st Jul 20154:00 pmRNSAcquisition and Issue of Consideration Shares
21st Jul 20157:00 amRNSTrading Update
18th Jun 20157:00 amRNSConfirmation of Quarterly Interim Dividend
17th Jun 20152:53 pmRNSCompany Secretary Appointment
2nd Jun 201512:58 pmRNSNotification of Major Interest In Shares
21st May 20157:00 amRNSFull Year Results
7th May 201512:10 pmRNSNotification of Major Interest in Shares
1st May 20153:28 pmRNSNotice of Results
15th Apr 20154:11 pmRNSNotification of Major Interest in Shares
14th Apr 20155:39 pmRNSNotification of Major Interest in Shares
2nd Apr 20155:09 pmRNSConfirmation of Quarterly Interim Dividend
26th Mar 201511:16 amRNSDirector/PDMR Shareholding
6th Mar 20158:50 amRNSEPRA Index Inclusion
4th Feb 20157:00 amRNSTrading Update
30th Jan 20159:42 amRNSNotification of Major Interest in Shares
29th Jan 20153:56 pmRNSNotification of Vesting of Share Award to PDMR
28th Jan 20158:21 amRNSAdmission of Assura plc shares
27th Jan 20151:53 pmRNSCourt hearing approves new corporate structure
23rd Jan 20152:27 pmRNSPublication of Prospectus
23rd Jan 201511:08 amRNSTR-1: Notification of Major Interest in Shares
14th Jan 201512:42 pmRNSResults of Shareholder Meetings
12th Jan 20157:00 amRNSForward funding and acquisition update
7th Jan 20157:00 amRNSAssura completes Sudbury Community Health Centre
17th Dec 20145:27 pmRNSPosting of Shareholder Circular & Meeting Notices
17th Dec 201410:16 amRNSAcquisition of a medical centre for £10.1 million
16th Dec 201412:12 pmRNSNew Corporate Structure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.